Employment

• 2008-present, Head, Laboratory of Pharmacokinetics and Therapeutic Drug Monitoring, Unit of Clinical Pharmacology, L. Sacco University Hospital, Milano, Italy
• 2016-present, Coordinator of the outpatient clinics for the management of polytherapies in HIV-infected patients, L. Sacco University Hospital, Milano, Italy
• 2004-2013, Component (Pharmacologist) of the Ethical Committee of the Scientific Institute E. Medea, Bosisio Parini, Lecco, Italy
• 2003-2008, Component (Pharmacologist) of the Ethical Committee of the Bolognini Hospital of Seriate, Bergamo, Italy
• 2004-2008, Head, Unit of Pharmacology and Pharmacogenetics, Mario Negri Institute for Pharmacological Research, Bergamo, Italy
• 1997-2003, Research fellow, Mario Negri Institute for Pharmacological Research, Bergamo, Italy

Academic commitments

• 2010-present, Assistant professor in Pharmacology, Faculty of Medicine, University of Milano, Italy
• 2003-2011, Assistant Professor, Master in Transplant Medicine, University of Milano Bicocca, Italy
• 2005-2008, Educational coordinator, Maastricht University (Belgium), within the Research Elective Agreement with the Mario Negri Institute for Pharmacological Research, Bergamo, Italy
• 2004-2008, Assistant Professor, Master in Clinical Research, University of Milano, Italy
• 2013-2017, Assistant Professor, Master in Pharmacovigilance and Pharmacoepidemiology, University of Naples, Italy

Education & Certification

• 1984-1989, High school diploma in Chemistry (Bergamo, Italy)
• 1990-1995, Pharmacy Degree (University of Milano, Italy)
• 1997-2000, Post-graduation specialization in Pharmacological Research (Mario Negri Institute for Pharmacological Research, Bergamo, Italy)
• 1998-2001, Post-degree Specialization in Pharmacology (University of Milano, Italy)
• 2001-2005, PhD in Biomedical Sciences (Open University, London, UK)

Professional Activities

• 2005-present, International Association of Therapeutic Drug Monitoring and Clinical Toxicology
• 2006-present, Italian Society of Pharmacology
• 2016-present, Italian Society of Infectious Diseases and Tropical Medicine
• 2019-present, European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
• 2009-2016, American College of Clinical Pharmacology
• 2018-present, Italian Federation of Human and Animal Mycology

Awards

• 2001, Winner of the E. Cofferati award for the research activity in the field of immunosuppressant pharmacology
• 2010, Winner of the D.E.I. Onlus Foundation award for the best emerging profiles in the field of clinical pharmacology

Publications / scientific activities

• Author of nearly 250 publications on peer reviewed indexed international journals, cited more than 6500 times, H-index: 38
• 7 book chapters
• Invited speaker for nearly 50 international congresses
• Invited speaker for nearly 200 national congresses
• Referee activities for dozens of indexed international journals (> 500 manuscripts reviewed)
• Member of the editorial board of European Journal of Drug Metabolism and Pharmacokinetics
• Member of the editorial board of Therapeutic Drug Monitoring
• Vice chair of the anti-infective committee within the IATDMCT society
• Member of the ESCMID PK/PD of Anti-Infectives Study Group
• Member of the board of directors of the Italian Federation of Human and Animal Mycology

Main clinical/research activities

• Therapeutic drug monitoring (mainly anti-infective agents, immunosuppressants, and central nervous system drugs)
• Pharmacokinetic studies both in healthy volunteers and in patients
• Application of pharmacogenetics as diagnostic tool for the optimization of drug therapies
• Antimicrobial stewardship
• Study and assessment of potential drug-drug interactions in real life settings
• Evaluation of potential inappropriate drug prescribing in fragile patients (deprescribing)
• Development and validation of analytical methods for the quantification of drugs in different biological matrices

Vision Statement

I envisage the future of the IATDMCT society as the key player for the tailoring of drug therapy in increasingly complicated patients (elderly, with comorbidities and heavy polypharmacy) at the bedside, taking advantage from the presence of active members with excellences and expertise in several fields. The accomplishment of this task requires, however, a day-by-day, two-way strict collaboration with specialists from different medical disciplines. In other words, the labs need to meet/match the clinics!

Employment

• Since 2019 (professor of Clinical Pharmacy)
  • University of Sydney, Faculty of Medicine and Health, School of Pharmacy, Sydney, Australia
  • Westmead Hospital, Western Sydney Local Health District, Sydney, Australia
• 2013-2018 (hospital pharmacist – associate professor)
  • University Medical Center Groningen, Groningen, the Netherlands
• 2009-2013 (hospital pharmacist – assistant professor)
  • University Medical Center Groningen, Groningen, the Netherlands
• 2005-2008 (hospital pharmacist – in residency)
  • University Medical Center Groningen, Groningen, the Netherlands
• 2002-2004 (pharmacist)
  • University Medical Center Groningen, Groningen, the Netherlands

Education & Certification

• 1995-2000 University of Groningen, MSc of Pharmacy
• 2000-2002 University of Groningen, PharmD
• 2005-2008 University Medical Center Groningen, residency in Hospital Pharmacy
• 2006-2009 University of Groningen, PhD in Medicine
• 2009-2011 University Medical Center Groningen, specialty training in Clinical Pharmacology

Professional Activities

Memberships: IATDMCT, NVZA (Dutch Society of Hospital Pharmacists), NvKFB (Dutch association for Clinical Pharmacology and biopharmaceutics), KNMP (Royal Dutch Society of Pharmacy), The International Union Against Tuberculosis and Lung Disease, ESCMID (European Society of Microbiology and Infectious Diseases, ASID (Australasian Society of Infectious Diseases, ISAP (International Society of Anti-Infective Pharmacology), ASM (American Society for Microbiology)

Committees: member of Human Ethics Research Committee, member of Scientific Advisory Committee, member of Clinical Trials Advisory Committee, member of Drug Committee WSLHD, Global Tuberculosis Network – Clinical Pharmacology Committee (chair)

IATDMCT activities: editorial board member TDM, past vice chair/past chair Anti-infective committee, past vice chair/past chair/current vice chair of Alternative Sampling Committee, Local Scientific advisory Committee IATDMCT Conference 2015, recipient of Victor Armstrong Young Investigator award 2015

Professional appointments: editorial board member Journal of Mass Spectrometry & Advances in the Clinical Lab, associate editor International Journal of Tuberculosis and Lung Disease, Expert advisor on Clinical Pharmacology of TB drugs WHO-ERS-ECDC Concilium

Number of publications: 301 publications in peer reviewed journals

Invited speaker: > 80 invited lectures on national and international conferences

Vision Statement

To influence patient-centred therapeutic drug monitoring and clinical toxicology at a global level, the IATDMCT should embrace international collaborative multidisciplinary research, thereby delivering high impact research. By developing an interactive regional training, education and professional development program, focused on early career researchers and clinicians, the IATDMCT will be positioned to attract creative and inspiring leaders of the future to deliver its promise to patients and their families to improve their health and well-being.

Employment

• 2016-present: Assistant Professor, Department of Pharmacology, Rennes University Hospital, Rennes
• 2012-2016: University Hospital Assistant, Department of Pharmacology, Rennes University Hospital, Rennes
• 2009-2012: Hospital Assistant, Department of Pharmacy, Hôpital La Pitié-Salpêtrière, Paris
• 2003-2009: Pharmacy residency, Rennes University Hospital, Poitiers University Hospital

Education & Certification

• 2010-2014: PhD in Experimental and Clinical Pharmacology: « Optimization of immunosuppressive therapy using pharmacological method». Paris Sud University. Faculty of Pharmacy. Ecole doctorale 425 Innovation thérapeutique : du fondamental à l’appliqué, Paris
• 2009: PharmD and Advanced Degree in Hospital Pharmacy, Rennes 1 University, Faculty of Pharmacy, Rennes
• 2008: Master in « Drug Toxicology », University Paris V, Faculty of Medicine, Paris
• 2007: University qualification in « Anti-infectious therapeutics », Rennes 1 University, Faculty of Medecine, Rennes
• 2003: Pharmacy residency national examination
• 1998/2003: Pharmacy studies, University of Caen, Faculty of Pharmacy, Caen

Professional Activities

• 2019-present: Co-coordinator of the Immunosuppressive subgroup of the national society « Société Française de Pharmacologie et Thérapeutique (SFPT) »
• 2019-present: Expert for drug-drug interactions at the French National Drug Regulatory Agency (ANSM)
• 2019-present: Member of the Pharmacology group of the French National Research Agency on HIV and Hepatitis (ANRS)
• 2019-present: member of national learning societies in transplantation: “Société Francophone de Transplantation” (SFT); “Société Française de Néphrologie, Dialyse et Transplantation” (SFNDT)
• 2018- present: Editor “La lettre de l’infectiologue”, Edimark
• 2017 – 2021: Member of the scientific counsel of the Faculty of Medicine of the Rennes 1 University
• 2014 – present: Member of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT), member of the Immunosuppressive drugs (ISD) committee of IATDMCT, Team leader “Intracellular therapeutic drug monitoring” of the ISD committee
• 2010 – present: Member of the national society « Société Française de Pharmacologie et Thérapeutique (SFPT) », Member of the national sub-group society « Groupe de suivi thérapeutique pharmacologique de la SFPT », Team leader « Immunosuppressive drugs »
• 2007/2008: President of the Poitiers Pharmacy Residents Association (AIPP)
• 68 international peer-reviewed articles
• 29 oral communications in scientific conferences
• 11 research grants as principal investigator from 2012 for a total amount of 778,500 euros

Employment

• 2018 – Medical Head Therapeutic Drug Monitoring, Synlab Holding Germany GmbH, MVZ Leinfelden-Echterdingen with teaching appointment at University of Tübingen
• 2003 -2018 – Senior scientist and Head TDM/Tox Section, Institute of Clinical Chemistry and Laboratory Medicine, Klinikum Stuttgart, Germany
• 1999- 2002 – Resident Dept. of Clinical Chemistry, University Göttingen, Germany
• 1995-1999 – Postdoctoral fellow, Dept. of Clinical Chemistry, University Göttingen, Germany
• 1992-1995 – Resident Dept. of Clinical Chemistry, University Sofia, Bulgaria
• 1991-1992 – Resident Dept. Internal Medicine, University Sofia, Bulgaria

Education & Certification

Academic Degrees:

• Dr. med. University Göttingen, Germany, 2002
• D-r (BG)., University Sofia, Bulgaria, 1990

Professional Registrations:

• Fellow European Board of Laboratory Medicine/Medical Biopathology (F.E.B.L.M./M.B.), 2013
• Clinical Pathology Consultant, 1996

Professional Activities

Professional Society Memberships:

• Vereinte Deutsche Gesellschaft für Laboratoriumsmedizin und Klinische Chemie (DGKL)
• International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT)
• Transplantation Society
• Bulgarian Academy of Sciences and Arts

Publications:

• 166 publications contributed to scientific journals and books on the following topics: therapeutic drug monitoring, drug metabolism, drug toxicity, development and evaluation of analytical methods, organ function tests, biomarkers of drug effects

Stipends and Awards:

• 2015 Grant from the Federal Ministry of Education and Research “Validation of GcfDNA based diagnostic test to detect organ damage after kidney transplantation”
• 2011 Grant of the Pathobiochemistry and Molecular Diagnostics Foundation, DGKL, Analytical validation of biomarker assays in transplantation medicine
• 2005 Young Investigator Award of the International Society for Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT)
• 2004 Grant of the Pathobiochemistry and Molecular Diagnostics Foundation, DGKL, Acyl glucoronides of mycophenolic acid
• 2002 Grant of the University Göttingen, Germany, Acyl glucuronide of mycophenolic acid
• 1998 Stipend Volkswagen Foundation, Germany, Metabolism of immunosuppressants
• 1996 Stipend Otvoreno Obschtestvo, Bulgaria, Pharmacokinetics of Taxol
• 1995 Tempus Phare stipend of the EU, Therapeutic Drug Monitoring

Varia:

• Reviews Editor of Therapeutic Drug Monitoring (TDM) (2018 - )
• Secretary IATDMCT (2017 -2021)
• Director of Education IATDMCT (2015 - 2017)
• Vice-Chair IATDMCT Communication Committee (2011 - 2017) and member of the Communication Committee till 2019
• Member of the IATDMCT Biomarkers in transplantation Working Group (2009 - )
• Coordinator “TDM of Everolimus” Consensus Project (2013-2016)
• Past-Chair of the IATDMCT Immunosuppressive Drugs Scientific Committee (2013–2015)
• Past Editor in Chief of the IATDMCT Newsletter “Compass” (2009 – 2015)
• Member of the LOC of the 11th IATDMCT Congress, 2011, Stuttgart, Germany
• Member of the Editorial Boards of Journal of Laboratory Medicine

Employment

• 2021-present, Advanced Research Project Professor, Pharmacometrics and Systems Pharmacology, Keio University Tonomachi Town Campus, Japan
• 1998-2021, Professor, Department of Clinical Pharmacokinetics and Pharmacodynamics, Keio University School of Medicine, Japan
• 1998-2007, Director of Hospital Pharmacy, Keio University Hospital, Japan
• 1993-1998, Associate Professor and Vice Director, Department of Pharmacy, Kobe University Hospital, Japan
• 1991-1992, Honorary Research Fellow, School of Pharmacy, University of Manchester, U.K.
• 1990-1993, Lecturer, Department of Pharmacy, Kyoto University Hospital
• 1985-1990, Instructor, Department of Pharmacy, Kyoto University Hospital

Education & Certification

• JSPHCS-certified Senior Oncology Pharmacist (JSOP), Japanese Society of Pharmaceutical Health Care and Sciences
• Board Certified Oncology Pharmacy Specialist (BCOPS), Japanese Society of Hospital Pharmacists
• Board Certified Supervisor Pharmacist, Japanese Society of Clinical Pharmacology and Therapeutics
• Board Certified Pharmacist, Japanese Society of Clinical Pharmacology and Therapeutics
• Pharmacist License of Japan
• 1983, Ph.D. from Graduate School of Pharmaceutical Sciences, Kyoto University, Japan
• 1980, MSc from Graduate School of Pharmaceutical Sciences, Kyoto University, Japan
• 1978, BSc from Faculty of Pharmaceutical Sciences, Kyoto University, Japan

Professional Activities

• 2019-2021, IATDMCT President
• 2017-2019, IATDMCT President-Elect
• 2013-2017, IATDMCT Secretary (2 terms)
• 2017, Chairman, 15th IATDMCT Congress 2017 in Kyoto
• 2015-2017, Chair of Scientific Committee “TDM in Oncology”
• Editorial Board, Therapeutic Drug Monitoring
• 2005-2011, President, Japanese Society of Therapeutic Drug Monitoring (JSTDM)
• Plenary Lecturer at 14th Congress of IATDMCT 2015 in Rotterdam
• Plenary Lecturer at 12th Congress of IATDMCT 2011 in Stuttgart
• Invited speaker at IATDMCT Regional Meeting in Guangzhou, China, 2016
• Invited speaker at IATDMCT Regional Meeting in Sibiu, Romania, 2014
• Invited speaker at IATDMCT Regional Meeting in Beijing, China, 2010
• Symposium speaker and organizer at the IATDMCT Congresses (Vienna in 1995, Cairns in 1999, Montreal in 2009)
• Number of peer reviewed original articles: 183
• Book chapters and Review articles: 250
• Invited lectures at international conferences: 46
• Invited lectures at Japanese national conferences: 117
• Dr. Tanigawara was distinguished as “Highly Cited Researcher” by Thomson Reuters ISI database. His research interests include clinical pharmacokinetics, pharmacodynamics and pharmacogenomics and their applications to TDM. He also investigates multi-omics biomarkers by means of MS-based proteomics and metabolomics.

Other academic and professional appointments

• 2003-present, Executive Board member, Japanese Society of Therapeutic Drug Monitoring (JSTDM)
• 2015-present, Executive Board member, Japanese Society of Clinical Oncology (JSCO)
• 2018-2020, Secretary of International Society of Pharmacometrics (ISoP)
• 2006-present, President, Population Approach Group in Japan (PAGJA), which was renamed as ‘Pharmacometric Approach Group in Japan’
• 2016-present, Co-chair, Focus Group “Modeling and Simulation,” International Society for Study of Xenobiotics (ISSX)
• 2011, Fellow of the Japanese Society for Study of Xenobiotics (JSSX)
• 2007-2009, Delegate for the Board of Pharmaceutical Sciences, International Pharmaceutical Federation (FIP)
• 2005-2008 and 2010-2014, Executive Board member, Japanese Society of Clinical Pharmacology and Therapeutics
• 2008-2016, Executive Board member, Japanese Society of Pharmaceutical Health Care and Science
• 2007-2009, Executive Board member, The Pharmaceutical Society of Japan
• 2005-present, Council member, Japanese Society of Clinical Oncology
• 2007-present, Council member, Japanese Society of Medical Oncology
• 2009-present, Council member, Japanese Cancer Association
• 2003-present, Council member, Japanese Society of Chemotherapy
• 2003-present, Council member, Japanese Society for Pharmacoepidemiology
• 2002-present, Associated Editor, Cancer Science
• 2005-present, Editorial Board, Japanese Journal of Clinical Oncology
• 2010-present, Editorial Board, The Japanese Journal of Antibiotics
• 1999-2001, Editorial Board, European Journal of Pharmaceutical Sciences

Employment

• Since 2020: Head of Research & Teaching, Pharmacy, member management team Erasmus MC, Rotterdam, The Netherlands
• Since 2017: Associate Professor of Clinical Pharmacometrics, Erasmus MC, The Netherlands
• Since 2011: Supervisor residency Clinical Pharmacology, Erasmus MC, The Netherlands
• Since 2010: Hospital Pharmacist-Clinical Pharmacologist, TDM and Toxicology, Erasmus MC, The Netherlands
• 2009-2010: Residency Clinical Pharmacology, VU University Medical Center, Amsterdam, The Netherlands
• 2006-2009: PhD candidate Nephrology VU, University Medical Center, Amsterdam, The Netherlands
• 2003-2009: Residency Hospital Pharmacy, Meander Medical Center, Amersfoort, The Netherlands

Education & Certification

• Pharmacy University Utrecht, 1996-2003
• BROK, GCP guidelines training
• ISO15189 auditor
• Teaching qualification
• Hospital Pharmacy residency 2003-2009, Meander Medical Center, Amersfoort
• Clinical Pharmacology residency, 2009-2010, VU University Amsterdam

Professional Activities

Publications:

• 136 Peer-reviewed publications (https://pubmed.ncbi.nlm.nih.gov/?term=koch+bc&sort=date)

Activities in IATDMCT:

• Member of the Alternative Sampling Committee
• Member of the Anti-infectives Committee
• Editorial Board Therapeutic Drug Monitoring

Executive Committee:

• EPASG, PK/PD of anti-infectives committee, European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
• Member of SWAB board, Antibiotic Surveillance Working Group, the Netherlands and Guidelines committee
• President Female Academic Network VENA, Rotterdam (2015-2010)
• Board member Dutch knowledge Center Psychiatry and Pregnancy (LKPZ) (2013-2018)

Committees:

• Guidelines committee SWAB
• Member section Clinical Pharmacology Unite Europeene des Medecins Specialistes (UEMS Europe)
• Registration committee Dutch Clinical Pharmacologists (NVKFB)
• Medical Ethical Board Erasmus MC
• Antibiotic committee Erasmus MC
• Registration committee Dutch hospital pharmacists (NVZA SRC)
• National Education program hospital pharmacists (PUOZ), (2011-2016)
• Scientific Board PAO Pharmacy, National Educational Office Pharmacists (2011-2016)
• Member Research Foundation Flanders (FWO), Stategic and Applied Program, Brussels, Belgium

Memberships:

• Member of International Society of Pharmacometrics (ISoP)
• Member of International Society of Anti-infective Pharmacology ( ISAP)
• Member of American Society for Clinical Pharmacology and Therapeutics
• Member of European Association for Clinical Pharmacology and Therapeutics
• Member of ESCMID

Editorial boards:

• Sleep-Wake Research in the Netherlands, 2008-2010
• Current Clinical Pharmacology, since 2017
• Therapeutic Drug Monitoring, since 2020

Professional appointments:

• Psyfar, education company (Prelum) for education in psychopharmacology (2017-2019)
• Advisory Board Pharmacy Universitas Gadjah Mada Indonesia, since 2019
• Scientific committee Universitas Muhammadiyah Yogyakarta, since 2020

Invited talks 2019-2021:

• GGG congress Dolphin studie, Amsterdam 4-4-2019
• NVKF & B 12 april 2019, PK/PD of antibiotics
• IATDM & CT Iguazu (Brasil September 2019): model-based dosing en Antibiotic intensive Care
• Pharmacometrics Meeting Tokyo January 2020
• Online IATDMCT 2020, PK/PD in psychiatry
• Online IATDMCT 2020, Alternative matrices TDM
• Antibiotica bij kids, maart 2021
• EATRIS Health RI, model-based dosing in pediatrics, 2021, digital
• ZonMW GGG congress, Safety and pharmacokinetics of children with autism, 15 april 2021

Employment

• Senior Specialist, Clinical Microbiology and Infectious Diseases
  Clinical lead, anti-infectives therapeutic drug monitoring group
  St. Vincent’s Hospital, Sydney, Australia
• Visiting Medical Officer, St. Vincent's Private Hospital, Sydney
• Visiting Medical Officer, Sacred Heart Hospice, Sydney
• Conjoint Professor, School of Medicine, University of New South Wales
• Adjunct Professor, Faculty of Science, University of Technology, Sydney

Education & Certification

• Fellow of the Royal College of Pathologists of Australasia
• Fellow of the Royal Australasian College of Physicians
• Bachelor of Medicine and Bachelor of Surgery, Honours Class I
• Bachelor of Science (Medicine), Honours Class I

Professional Activities

• Founding member and Past President of the Australasian Society for HIV Medicine
• Past President, Transplant Infectious Diseases (a section of The Transplant Society)
• International Councillor, International Association of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT) 2017-2019
• Director of Education IATDMCT 2019-
• Co-chair of the Anti-Infectives group IATDMCT 2016-
• Over 200 publications in refereed journals
• Reviewer for over 12 journals
• Associate editor, Transplantation

Professional Societies:

• Royal Australasian College of Physicians
• Royal College of Pathologists of Australasia
• International Association for Therapeutic Drug Monitoring and Clinical Toxicology
• Australasian Society for Infectious Diseases
• Australasian Society for HIV Medicine
• Australasian Society for Antimicrobials
• International Immuno-compromised Host Society
• International Society for Heart and Lung transplantation
• Transplant Infectious Diseases
• The Transplant Society
• Australasian Society for Clinical Pharmacology and Toxicology
• Animal Management in Remote and Indigenous Communities
   
• 1986- Member, Drug and Therapeutics Committee, St. Vincent's Hospital
• 1988- Accreditor, National Association of Testing Authorities
• 1989-97 Member, N.S.W. State Committee, Royal Australasian College of Physicians
• 1990- Examiner, Royal Australasian College of Pathologists
• 1993-2014 Member, Tuberculosis Advisory Committee, N.S.W. Department of Health
• 1995 Visiting lecturer, University Santo Tomas, Manila, Philippines
• 1997-99 President, Australasian Society for HIV Medicine
• 2000-10 Member, Pharmacology and Toxicology Working Group, National Centre in HIV Epidemiology and Clinical Research
• 2009-13 Co-chair, Australian and New Zealand Mycoses Interest Group
• 2010- Examiner, Royal Australasian College of Physicians
• 2012- Scientific Committee member (HIV and Infectious Diseases), International Association for Therapeutic Drug Monitoring and Clinical Toxicology
• 2012- Scientific Committee member, International Society for Heart and Lung Transplantation
• 2012- Scientific Committee member, Transplant Infectious Diseases
• 2013- President, Transplant Infectious Diseases
• 2013- Board Member, Medical Advances without Animals
• 2014- Visiting Lecturer, The Academy of Medicine, Singapore
• 2014- Visiting International Professor, Royal College of Pathologists of Australasia
• 2014- Member, ESPAG group, ECCMID
   
• Proposer and Co-Convener – joint IATDMCT/TID/The Transplant Society (TTS) Conference, Hong Kong, 2016 in conjunction with TTS Conference
• Keynote and invited speaker at many national and international meetings including ICAAC (Denver 2012), ISHLT (Montreal, 2012; San Diego, 2013), The World Transplant Congress (San Francisco 2014), Transplant Infectious Diseases (Berlin, 2012; Vienna, 2013; Barcelona 2014), ISHAM (Melbourne 2015), Transplant Infectious Diseases (2014, 2015, 2016), IATDMCT (Salt Lake City, 2012, Rotterdam, 2016, Kyoto 2017, Brisbane 2018, Iguassu 2019, Virtual ‘Banff’ meeting 2020))
• Convener and speaker at a number of regional Mycology Master Classes run under the auspices of the International Society of Human and Animal Mycology (ISHAM) including Phuket (2011), Singapore (2012), Seoul (2013) and Penang (2014) and Bangkok (2016)
• Coordinator of the Clinical Stream at the ISHAM conference in Melbourne (May 2015) and convener of the pre-congress workshop on Therapeutic Drug Monitoring in Fungal Infections
• Invited speaker, 5th Annual National conference on Therapeutic Drug Monitoring and First Asia-Pacific Symposium on Therapeutic Drug Monitoring. Beijing, September 2015 and 6th Annual National Congress on Therapeutic Drug Monitoring. Nanjing, China. September 2016
• Invited speaker and representative of IATDMCT with multiple presentations. The National Symposium on Therapeutic Drug Monitoring, Vellore, India, July 2017
• Congress organizing committee, member of the scientific committee and invited speaker. 16th IATDMCT, Brisbane, Australia. September 2018
• Invited speaker, 10th National Annual Conference of TDM-China. September 2020
• Convener and organizer, first Asia-Pacific TDM workshop to be held under the auspices of IATDMCT in conjunction with the Asia Pacific Conference on Clinical Microbiology and Infection. November 2020 (postponed due to COVID-19)
• Convener and organizer, Asia – Pacific TDM meeting (virtual) – October 2021
• Convener and organizer, South American Anti-Infective TDM workshop (virtual) – March 2022
• Extensive connections with the Asian region and an invited speaker at many conferences within Asia, including Malaysia, Hong Kong, Singapore, Indonesia, India, Japan and China
• Reviewer of approximately 15 manuscripts per year for the past 10 years in local and international journals

Employment

• 1999-2004: PhD in Medical Sciences (performed @ Faculty of Medical Sciences at Ghent University)
• 2004-2007: Postdoc @ Faculty of Sciences (VIB - Ghent University)
• 2007-Jan 2013: Postdoc @ Faculty of Pharmaceutical Sciences (Lab of Toxicology, Ghent University)
• Feb 2013-Jan 2018: Assistant-Professor (“Docent tenure-track”) (Lab of Toxicology, Ghent University)
• Feb 2018-now: Associate Professor (“Hoofddocent”) (Lab of Toxicology, Ghent University)

Education & Certification

• 1999: Pharmacist (Ghent University)
• 2004: PhD in Medical Sciences (performed @ Faculty of Medical Sciences at Ghent University)
• Recognized by the Department of Justice as expert for determination of alcohol in cases of drunk driving (since Sept 4, 2014) and for expert advice in cases involving toxicological expertise
• Director of the ISO 17025/1595 accredited Reference Laboratory Ref4U, implementing reference measurement procedures for e.g. thyroid hormones and vitamin D

Professional Activities

Teaching activities
Responsible for the following courses:

• General Toxicology (3rd Bachelor)
• Bioanalysis (Master)
• Chemical Criminalistics (Master)
• Drug Toxicity (Master)
• Supplements in Toxicology: advanced studies (MaNaMa Clinical Biology)
• Co-responsible for Bioanalytical Practical Course

Research activities (overview & selection):

• Publications (also see links: Google Scholar; Pubmed; http://orcid.org/0000-0001-7126-348X) General Overview (based on Web of Science ranking 2019):
• >160 peer-reviewed scientific publications
  • >30% of all publications is in top 10% journals;
  • >60% of all publications is in Q1 journals;
  • >95% of all publications is in Q1 & Q2 journals;
  • On ~2/3 of all publications, C. Stove is first author or lead/corresponding author.
• H-index of 32 (Web of Science) – 39 (Google Scholar)
• Citations: >3000 (Web of Science) - >4500 (Google Scholar)
• Acquisition of competitive research funding: ~1.75M€ projects + ~50 person-years (PhD students & postdoc)
• Promotor of 15 defended PhDs and 8 ongoing PhDs
• 3 main research lines can be distinguished:
  • Alternative sampling strategies (e.g. dried blood microsampling, hair analysis)
  • Development of bio-assays for monitoring of activation of G-protein coupled receptors
  • Analysis of vitamers (amongst which folates and thiamins), their precursors and degradation products, in plant material and biological material (blood)
• Editorial Board Member of Clinical Biochemistry (Associate Editor), Journal of Analytical Toxicology, Therapeutic Drug Monitoring
• Guest Editor for Special Issues of the peer-reviewed journals Bioanalysis, Forensic Science International, Frontiers in Chemistry, Journal of Analytical Toxicology, Therapeutic Drug Monitoring
• Peer review: from 2016 to now: over 380 peer reviews, for over 60 scientific journals. Journals for which ≥20 reviews were performed during the past 5 years: Analytical Chemistry, Analytical and Bioanalytical Chemistry, Bioanalysis, Clinical Biochemistry, Forensic Science International, Journal of Chromatography B, Journal of Pharmaceutical and Biomedical Analysis, Therapeutic Drug Monitoring
• Involved in the organization of international scientific congresses (TIAFT, IATDMCT, EBF, CPSA, MSACL), as part of the scientific committee; main organizer of the annual TIAFT conference in Ghent, in 2018 (~700 attendants)
• >200 oral and poster presentations at national and international conferences (many on invitation)

Member of scientific societies:

• Toxicological Society of Belgium and Luxemburg (BLT) (Board Member)
• Belgian Environmental Mutagen Society (BEMS) (Board Member)
• The International Association of Forensic Toxicologists (TIAFT) (Board Member)
• International Association for Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) (Council Member – 2 terms); Former chair & vice-chair of the Alternative Sampling Strategies Committee
• Belgisch Genootschap voor Gerechtelijke Geneeskunde (BGGG) (Board Member)
• Part of national (BOF & FWO (Med1)) and international (UK, The Netherlands, France, Switzerland, Czech Republic) project assessment committees
• External assessor of applications for academic positions (several universities in the UK)
• Member of >60 PhD Evaluation committees (UGent (primarily Fac. Pharmaceutical Sciences, but also Fac. Sciences & Fac. Medicine & Health Sciences), KULeuven, UK, Australia, The Netherlands, Denmark)
• Granted patent: Dried blood sample analysis: granted patents: EP3359950A1 (EU) and US10222324 (US) (hyperlink). This has also led to commercialization (by CAMAG, Basel, Switzerland)

Service Activities (external):

• Head of the Laboratory of Forensic Toxicology, follow-up of routine casework in judicial cases since Jan 1st 2008; end responsible (lab director) since Sept 15, 2014. Provided many hundreds of reports to the Department of Justice since then.
• Core member of the Forensic Institute of Ghent University (FI-UGent).
• Toxicological consultancy; ad hoc toxicological expertise (e.g. Superior Health Council, Fonds Medische Ongevallen, FAGG – Committee on Herbal Medicinal Products for Human Use).
• Provision of toxicological expertise in the train disaster at Wetteren (05/2013 - on-site expertise, scientific publications, part of the Superior Health Council, report to fed. Min. of public health, …).
• Recognized by the Department of Justice as expert for determination of alcohol in cases of drunk driving (since Sept 4, 2014) and for expert advice in cases involving toxicological expertise.
• Director of the ISO 17025/1595 accredited Reference Laboratory Ref4U, implementing reference measurement procedures for e.g. thyroid hormones and vitamin D.

Dr. Ryuji Kato is an Associate Professor of Cardiovascular Pharmacotherapy and Toxicology at Osaka University of Pharmaceutical Sciences, Osaka, Japan. He completed his master’s degree in 2000 at Osaka University and began his career as a pharmacist at the Yokkaichi Social Insurance Hospital (Mie, Japan). He then moved to Osaka University of Pharmaceutical Sciences as an Assistant Professor. In 2008, he received his PhD in Pharmaceutical Sciences.

His research interests primarily include the appropriate use of pharmaceutical products. He has conducted extensive research on pharmacokinetics, drug-drug interactions (chelation complexes, drug-drug interactions on cytochrome P450 or via transporters), and serious adverse side effects (QT prolongation, drug induced liver injury, interstitial pneumonia, Stevens-Johnson syndrome, and toxic epidermal necrolysis).

He is the author or co-author of approximately 70 peer-reviewed manuscripts. Dr. Kato is a member of the following academic societies: International Association of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT), Japanese Society of Therapeutic Drug Monitoring (JSTDM), Society of Toxicology (SOT), Pharmaceutical Society of Japan, and Japanese Society of Nephrology and Pharmacotherapy (JJNP). He has been a member of IATDMCT Communication Committee since 2015 and is an inspector for JSTDM.

Employment

• 2019 - – Professor of Pediatrics, Clinical Scholar, Department of Pediatrics, University of Southern California Keck School of Medicine, Los Angeles, CA, USA
• 2013 – 2018 – Associate Professor of Pediatrics, Clinical Scholar, Department of Pediatrics, University of Southern California Keck School of Medicine, Los Angeles, CA, USA
• 2002 – 2013 – Assistant Clinical Professor of Pediatrics, Department of Pediatrics, University of Southern California Keck School of Medicine, Los Angeles, CA, USA

Education & Certification

• 1991 – B.A. (Highest Distinction honors), Molecular and Cell Biology (Neurobiology) University of California at Berkeley, Berkeley, CA
• 1996 – M.D., University of California at Davis, Davis, CA

Post-Graduate Training:

• 1996 – 1999 – Internship and Residency, Pediatrics, Rainbow Babies and Children’s Hospital, University Hospitals of Cleveland, Cleveland, OH
• 1999 – 2002 – Fellowship, Pediatric Infectious Diseases, Fellowship, Pediatric Clinical Pharmacology, Rainbow Babies and Children’s Hospital, University Hospitals of Cleveland, Cleveland, OH
• 2011 – Master’s Degree in Clinical and Biomedical Investigations, University of Southern California, Los Angeles, CA

Professional Activities

Publications:

• 149 peer reviewed manuscripts
• One textbook - Individualized Drug Therapy for Patients: Basic Foundations, Relevant Software and Clinical Applications 1st Edition, 2016. Editors: Jelliffe RW, Neely MN.
• 9 book chapters

Speaking engagements:

• Over 100, including more than 40 international invitations

IATDMCT:

• Member since 2011
• Attendee at every congress since joining
• Councilor 2017-2019
• Member Anti-Infective Scientific Committee and Pharmacometric Committee
• Former Vice-chair and Chair of Anti-Infective Scientific Committee
• Congress Scientific Committee Member IATDMCT Rome 2021 and Iguacu 2019
• Recipient 2017 Patzalos Prize

American College of Clinical Pharmacology:

• Fellow since 2011
• Regent 2015-2020
• Roger Jelliffe Award in Individualized Therapy 2020
• Excellence in Achievement 2021

Employment

• Since 2014: Associate Professor in the Pharmacology, Toxicology Department, University Hospital of Limoges/ INSERM U1248, University of Limoges, Limoges (France)
• 2010-2014: Assistant Professor in the Pharmacology, Toxicology Department, University Hospital of Limoges/ INSERM U1248, University of Limoges, Limoges (France)
• 2008-2011: PhD at the INSERM U850, University of Limoges, Limoges (France)
• 2004-2008: Pharmacy residency at the University Hospital of Limoges, Limoges (France)
• 1998-2004: PharmD at the University of Toulouse (Faculty of Pharmacy), Toulouse (France)

Education & Certification

• 2019 Accreditation to supervise research (HDR – French postdoctoral degree)
• 2011 PhD degree, Université Limoges, France
• 2008 PharmD degree, Faculty of Pharmacy, Toulouse, France
• 2007 Master degree, Université Paris V, Paris, France

Professional Activities

Research interest:

• Pharmacogenetics
• Pharmacometrics
• Application of machine learning to drug individualisation

Awards:

• IFCC-Gérard Siest Award (Young Scientist Award for Distinguished Contributions in Pharmacogenetics) 2020
• Award of the French Society of Pharmacology and Therapeutics, 2015 and 2017

Invited conference and oral communications:

• 26 oral communications (12 in France and 14 abroad)
• 9 invited conferences Academic and Industry (5 in France and 4 abroad)

Positions in learned societies:

• Member of the ISOP-ACCP Clinical Pharmacometrics Special Interest Group Steering Committee (Chair Dr. M. Neely) 2017-2020
• Co-chair of Pharmacometrics committee of IATDMCT since 2018

Membership in learned societies:

• Member of International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT)
• Member of European Association for Clinical Pharmacology and Therapeutics (EACPT)
• Member of Société Française de Pharmacologie et Thérapeutique (SFPT)
• Member of groupe Suivi Thérapeutique Pharmacologique (groupe STP) of SFPT
• Member of Réseau National de Pharmacogénétique (RNPGx)

Consensus conferences:

• Participated in 2 international consensus conferences about immunosuppressive drugs (Tacrolimus and MMF)

Number of publications:

• 78 peer-reviewed manuscripts

Employment

• 01/2020 – present: Director of Toxicology Counseling Center of Hunan Province (TCCH), China
• 01/2019 – present: Deputy Director of Scientific Research Department, the Second Xiangya Hospital of Central South University, China
• 09/2017 – present: Associate Professor of Pharmacy, the Second Xiangya Hospital of Central South University, China
• 05/2013 – 06/2014: Postdoctoral Research Fellow, University of Illinois at Chicago, USA
• 07/2010 – 08/2017: Clinical Pharmacist, the Second Xiangya Hospital of Central South University, China

Education & Certification

• 2010: Ph.D. in Pharmacology, Central South University, China

Professional Activities

• Executive and committee positions held:
  • 09/2019 – present: Councilor of IATDMCT
  • 10/2018 – present: Chair of Young Scientist Committee, Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society (CHINA-TDM)
  • 09/2018 – present: Member of TDM in Oncology Committee, IATDMCT
  • 09/2016 – present: Member of Young Scientist Committee, IATDMCT
  • 07/2015 – present: Member of Pharmacometrics Committee, Chinese Pharmacological Society
• Activities in IATDMCT:
  • [Co-Chair of Symposium, Invited speaker]. IATDMCT Congress 2019; Sept 22-26, 2019, Foz do Iguassu, Brazil
  • [Executive chair]. The First CHINATDM-IATDMCT Young Scientist Joint Symposium at the 9th International Xiangya Clinical Pharmacy Forum; Sept 5-7, 2019, Changsha, China
  • [Guest speaker]. The Third JSTDM-IATDMCT Young Scientist Joint Symposium at the 36th Annual Meeting of the Japanese Society of Therapeutic Drug Monitoring; May 25-26, 2019, Tokyo, Japan
  • [Oral presentation]. IATDMCT Congress 2018; Sept 16-19, 2018, Brisbane, Australia
  • [Poster presentation]. IATDMCT Congress 2017; Sept 24-27, 2017, Kyoto, Japan
• Publications:
  • Published 50 research papers in Science Citation Index journals